Tandem Diabetes Care Inc. (TNDM)
NASDAQ: TNDM
· Real-Time Price · USD
13.55
-0.32 (-2.31%)
At close: Oct 13, 2025, 3:59 PM
-2.31% (1D)
| Bid | 13.5 |
| Market Cap | 915.9M |
| Revenue (ttm) | 1.12B |
| Net Income (ttm) | -205.45M |
| EPS (ttm) | -3.08 |
| PE Ratio (ttm) | -4.4 |
| Forward PE | -15.22 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 13.61 |
| Volume | 78,837 |
| Avg. Volume (20D) | 2,124,403 |
| Open | 13.69 |
| Previous Close | 13.87 |
| Day's Range | 13.50 - 13.78 |
| 52-Week Range | 9.98 - 38.28 |
| Beta | 1.49 |
| Ex-Dividend Date | n/a |
About TNDM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TNDM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TNDM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTandem Diabetes Care Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+9.78%
Tandem Diabetes Care shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
-19.94%
Tandem Diabetes Care shares are trading lower after the company reported mixed Q2 financial results and narrowed its FY25 sales guidance below estimates.
2 weeks ago · businesswire.com
Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United StatesSAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--t:slim X2 insulin pump with Control-IQ+ technology now cleared for use with Lyumjev ultra-rapid acting insulin in the U.S.
